Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.

AJR. American journal of roentgenology - 1 Mar 2015

DeLeo Michael J, Domchek Susan M, Kontos Despina, Conant Emily, Chen Jinbo, Weinstein Susan

Abstract excerpt

OBJECTIVE. The purpose of this article is to assess the difference in fibroglandular volume and background parenchymal enhancement in BRCA1 and BRCA2 mutation carriers on contrast-enhanced breast MRI (CE-MRI) performed before and immediately after risk-reducing salpingo-oophorectomy (RRSO). MATERIALS AND METHODS. We retrospectively compared fibroglandular volume and background parenchymal enhancement in 55 female...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Organ Size

Share to Ovariectomy

Share to Postoperative Period

Share to Salpingectomy

Source

Identifiers

PMID: 25714301
DOI: 10.2214/AJR.13.12146

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.PMID 25714301Read ↗

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.Semantic proximity Read ↗

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.Semantic proximity Read ↗

Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.Semantic proximity Read ↗

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.Semantic proximity Read ↗

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.Semantic proximity Read ↗

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Semantic proximity Read ↗

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.Semantic proximity Read ↗

Imaging Characteristics of Breast Cancers Detected During MRI-Based Surveillance in Hereditary Breast and Ovarian Cancer SyndromeSemantic proximity Read ↗

MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.